Top

Published in:

01-01-2016 | Neurologic Manifestations of Systemic Disease (A Pruitt, Section Editor)

Complications and Surveillance After Bariatric Surgery

Authors: Seth J. Concors, MD, Brett L. Ecker, MD, Richard Maduka, BS, Alyssa Furukawa, BA, Steven E. Raper, MD, Daniel D. Dempsey, MD, Noel N. Williams, MD, Kristoffel R. Dumon, MD

Published in: Current Treatment Options in Neurology | Issue 1/2016

Opinion statement

Bariatric surgery represents a durable and safe treatment modality for morbid obesity. Bariatric surgery results in weight loss by one of two—and possibly both—primary mechanisms, reducing the amount of tolerable intake (restrictive) and reducing the amount of nutrients absorbed by bypassing absorptive intestine (malabsorptive). These procedures have consistently demonstrated superior resolution of obesity and many associated co-morbid conditions as compared to medical management. Beyond the periprocedural complications of surgery, there are longitudinal risks such as weight regain, anatomic complications, and micronutrient deficiencies. Complications related to the anatomic alteration after bariatric surgery include internal herniation, marginal ulcers, dumping syndrome, and gastric band-related complications. Physicians who take care of bariatric patients at any point in their post-operative care must be vigilant for these complications, as they may necessitate urgent intervention or re-operation. Micronutrient deficiencies, which commonly occur after malabsorptive procedures, may present with a wide range of symptoms—including neuropathies, anemia, poor wound healing, and hair loss, among others. Deficiencies of vitamins and minerals frequently result in the need for long-term supplementation and may necessitate intravenous repletion when severe. Bariatric surgery may also alter the absorption of commonly prescribed medications, including anti-psychotic medications.

Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among us adults, 1999–2010. JAMA. 2012;307(5):491–7.CrossRefPubMed

Consensus Development Conference Panel. Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115(12):956–61.

Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.CrossRefPubMed

Ikramuddin S, Korner J, Lee W, et al. Roux-en-y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA. 2013;309(21):2240–9.PubMedCentralCrossRefPubMed

Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: A randomized clinical trial. JAMA Surg. 2015;150(10):931–40.

Ryan DH, Johnson WD, Myers VH, Prather TL, McGlone MM, Rood J, et al. Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study. Arch Intern Med. 2010;170(2):146–54.CrossRefPubMed

Reames BN, Finks JF, Bacal D, Carlin AM, Dimick JB. Changes in bariatric surgery procedure use in Michigan, 2006–2013. JAMA. 2014;312(9):959–61.PubMedCentralCrossRefPubMed

Campos GM, Rabl C, Roll GR, et al. Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass vs banding: results of a 2-cohort pair-matched study. Arch Surg. 2011;146(2):149–55.CrossRefPubMed

DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007;356(21):2176–83.CrossRefPubMed

10.

Iannelli A, Dainese R, Piche T, Facchiano E, Gugenheim J. Laparoscopic sleeve gastrectomy for morbid obesity. World J Gastroenterol : WJG. 2008;14(6):821–7.PubMedCentralCrossRefPubMed

11.

Moy J, Pomp A, Dakin G, Parikh M, Gagner M. Laparoscopic sleeve gastrectomy for morbid obesity. Am J Surg. 2008;196(5):e56–9.CrossRefPubMed

12.•

Bohdjalian A, Langer F, Shakeri-Leidenmühler S, Gfrerer L, Ludvik B, Zacherl J, et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and Ghrelin. Obes Surg. 2010;20(5):535–40. English. This is an important paper describing the outcomes after the VSG.CrossRefPubMed

13.

Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014;509(7499):183–8.PubMedCentralCrossRefPubMed

14.•

O’Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257(1):87–94. This is an important outcome focused paper on the long term co-morbidity resolution resulting from bariatric surgery.CrossRefPubMed

15.

Tevis S, Garren M, Gould J. Revisional surgery for failed vertical-banded gastroplasty. Obes Surg. 2011;21(8):1220–4. English.CrossRefPubMed

16.

Prachand VN, DaVee RT, Alverdy JC. Duodenal switch provides superior weight loss in the super-obese (BMI ≥50kg/m(2)) compared with gastric bypass. Ann Surg. 2006;244(4):611–9.PubMedCentralPubMed

17.

Booth H, Khan O, Prevost T, Reddy M, Dregan A, Charlton J, et al. Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study. Lancet Diabetes Endocrinol. 2014;2(12):963–8.CrossRefPubMed

18.

Dorman R, Abraham A, Al-Refaie W, Parsons H, Ikramuddin S, Habermann E. Bariatric surgery outcomes in the elderly: an ACS NSQIP study. J Gastrointest Surg. 2012;16(1):35–44. English.CrossRefPubMed

19.

Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.CrossRefPubMed

20.

Sjöström L, Lindroos A-K, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.CrossRefPubMed

21.

Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.CrossRefPubMed

22.

Arterburn DE, Olsen MK, Smith VA, et al. Association between bariatric surgery and long-term survival. JAMA. 2015;313(1):62–70.CrossRefPubMed

23.

Sugerman HJ, Felton 3rd WL, Salvant Jr JB, Sismanis A, Kellum JM. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology. 1995;45(9):1655–9.CrossRefPubMed

24.

Sugerman HJ, Felton WL, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg. 1999;229(5):634.PubMedCentralCrossRefPubMed

25.

Aurora A, Khaitan L, Saber A. Sleeve gastrectomy and the risk of leak: a systematic analysis of 4,888 patients. Surg Endosc. 2012;26(6):1509–15. English.CrossRefPubMed

26.

Smith MD, Adeniji A, Wahed AS, Patterson E, Chapman W, Courcoulas AP, et al. Technical factors associated with anastomotic leak after Roux–en–Y gastric bypass. Surg Obes Relat Dis. 2015;11(2):313–20.CrossRefPubMed

27.

Moon RC, Teixeira AF, Goldbach M, Jawad MA. Management and treatment outcomes of marginal ulcers after Roux-en-Y gastric bypass at a single high volume bariatric center. Surg Obes Relat Dis. 2014;10(2):229–34.CrossRefPubMed

28.

Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc. 2007;21(7):1090–4. English.CrossRefPubMed

29.

Ukleja A. Dumping syndrome: pathophysiology and treatment. Nutr Clin Pract. 2005;20(5):517–25.CrossRefPubMed

30.

Carrodeguas L, Szomstein S, Zundel N, Lo Menzo E, Rosenthal R. Gastrojejunal anastomotic strictures following laparoscopic Roux-en-Y gastric bypass surgery: analysis of 1291 patients. Surg Obes Relat Dis. 2006;2(2):92–7.CrossRefPubMed

31.

Takata MC, Ciovica R, Cello JP, Posselt AM, Rogers SJ, Campos GM. Predictors, treatment, and outcomes of gastrojejunostomy stricture after gastric bypass for morbid obesity. Obes Surg. 2007;17(7):878–84.CrossRefPubMed

32.

Higa K, Ho T, Boone K. Internal hernias after laparoscopic Roux-en-Y gastric bypass: incidence. Treatment and prevention. Obes Surg. 2003;13(3):350–4. English.CrossRefPubMed

33.

Eid I, Birch DW, Sharma AM, Sherman V, Karmali S. Complications associated with adjustable gastric banding for morbid obesity: a surgeon’s guide. Can J Surg. 2011;54(1):61–6.PubMedCentralCrossRefPubMed

34.

Brown WA, Egberts KJ, Franke-Richard D, Thodiyil P, Anderson ML, O’Brien PE. Erosions after laparoscopic adjustable gastric banding: diagnosis and management. Ann Surg. 2013;257(6):1047–52.CrossRefPubMed

35.

MacLean LD, Rhode BM, Sampalis J, Forse RA. Results of the surgical treatment of obesity. Am J Surg. 1993;165(1):155–62.CrossRefPubMed

36.

Carter PR, LeBlanc KA, Hausmann MG, Kleinpeter KP, de Barros SN, Jones SM. Association between gastroesophageal reflux disease and laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2011;7(5):569–72.CrossRefPubMed

37.

Patterson EJ, Davis DG, Khajanchee Y, Swanström LL. Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn. Surg Endosc Other Interv Tech. 2003;17(10):1561–5. English.CrossRef

38.

Berger JR. The neurological complications of bariatric surgery. Arch Neurol. 2004;61(8):1185–9.PubMed

39.

Bal BS, Finelli FC, Shope TR, Koch TR. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol. 2012;8(9):544–56.CrossRefPubMed

40.

Shankar P, Boylan M, Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition. 2010;26(11–12):1031–7.CrossRefPubMed

41.•

Tack J, Deloose E. Complications of bariatric surgery: dumping syndrome, reflux and vitamin deficiencies. Best Pract Res Clin Gastroenterol. 2014;28(4):741–9. This article reviews the many micronutrient deficiencies associated with Bariatric surgery.CrossRefPubMed

42.••

Levinson R, Silverman JB, Catella JG, Rybak I, Jolin H, Isom K. Pharmacotherapy prevention and management of nutritional deficiencies post Roux-en-Y gastric bypass. Obes Surg. 2013;23(7):992–1000. Another excellent review of micronutrient deficiencies associated with bariatric surgery and their potential complications.CrossRefPubMed

43.

Kumar N. Copper deficiency myelopathy (human swayback). Mayo Clin Proc. 2006;81(10):1371–84.CrossRefPubMed

44.

Juhasz-Pocsine K, Rudnicki SA, Archer RL, Harik SI. Neurologic complications of gastric bypass surgery for morbid obesity. Neurology. 2007;68(21):1843–50.CrossRefPubMed

45.

Dahlquist NR, Perrault J, Callaway CW, Jones JD. d-lactic acidosis and encephalopathy after jejunoileostomy: response to overfeeding and to fasting in humans. Mayo Clin Proc. 1984;59(3):141–5.CrossRefPubMed

46.

Hamad GG, Helsel JC, Perel JM, Kozak GM, McShea MC, Hughes C, et al. The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors. Am J Psychiatry. 2012;169(3):256–63.PubMedCentralCrossRefPubMed

47.

Seaman JS, Bowers SP, Dixon P, Schindler L. Dissolution of common psychiatric medications in a Roux-en-Y gastric bypass model. Psychosomatics. 2005;46(3):250–3.CrossRefPubMed

48.

Pournaras D, Footitt D, Mahon D, Welbourn R. Reduced phenytoin levels in an epileptic patient following Roux-en-Y gastric bypass for obesity. Obes Surg. 2011;21(5):684–5. English.CrossRefPubMed

Title: Complications and Surveillance After Bariatric Surgery
Authors: Seth J. Concors, MD
Brett L. Ecker, MD
Richard Maduka, BS
Alyssa Furukawa, BA
Steven E. Raper, MD
Daniel D. Dempsey, MD
Noel N. Williams, MD
Kristoffel R. Dumon, MD
Publication date: 01-01-2016
Publisher: Springer US
Published in: Current Treatment Options in Neurology / Issue 1/2016
Print ISSN: 1092-8480
Electronic ISSN: 1534-3138
DOI: https://doi.org/10.1007/s11940-015-0383-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Complications and Surveillance After Bariatric Surgery

Opinion statement

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Opinion statement

Please log in to get access to this content

Other articles of this Issue 1/2016

Use of Cannabinoids for Spasticity and Pain Management in MS

Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic

Usefulness of PET Imaging to Guide Treatment Options in Gliomas

Treatment of Susac Syndrome